Global Oral Rabies Vaccine Market Research Report 2025

Industry: Pharma & Healthcare

Published: 2025-03-02

Pages: 70 Pages

Report ld: 4356031

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description

The global market for Oral Rabies Vaccine was valued at US$ 116 million in the year 2024 and is projected to reach a revised size of US$ 415 million by 2031, growing at a CAGR of 20.3% during the forecast period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Oral Rabies Vaccine Market Size(US$)

M= millions and B=billions

Report Scope
This report aims to provide a comprehensive presentation of the global market for Oral Rabies Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Rabies Vaccine.

The Oral Rabies Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oral Rabies Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. 
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Oral Rabies Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Report Metric
Details
Report Title
Global Oral Rabies Vaccine Market Research Report 2025
Forecasted Market Size in 2031
US$ 415 million
CAGR(2025-2031)
20.3%
Market Size Available for Years
2025-2031
Global Oral Rabies Vaccine Companies Covered
Boehringer Ingelheim(Merial)
Ceva Santé Animale(Artemis Technologies)
Virbac
Global Oral Rabies Vaccine Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Oral Rabies Vaccine Market, Segment by Type
Modified Live Virus
Recombinant Vaccinia
Recombinant Adenovirus Vaccine
Global Oral Rabies Vaccine Market, Segment by Application
Government
Commercial
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oral Rabies Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oral Rabies Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Table of Contents

1 Oral Rabies Vaccine Market Overview
    1.1 Product Definition
    1.2 Oral Rabies Vaccine by Type
        1.2.1 Global Oral Rabies Vaccine Market Value Comparison by Type (2024 VS 2031)
        1.2.2 Modified Live Virus
        1.2.3 Recombinant Vaccinia
        1.2.4 Recombinant Adenovirus Vaccine
    1.3 Oral Rabies Vaccine by Application
        1.3.1 Global Oral Rabies Vaccine Market Value by Application (2024 VS 2031)
        1.3.2 Government
        1.3.3 Commercial
    1.4 Global Oral Rabies Vaccine Market Size Estimates and Forecasts
        1.4.1 Global Oral Rabies Vaccine Revenue 2020-2031
        1.4.2 Global Oral Rabies Vaccine Sales 2020-2031
        1.4.3 Global Oral Rabies Vaccine Market Average Price (2020-2031)
    1.5 Assumptions and Limitations

2 Oral Rabies Vaccine Market Competition by Manufacturers
    2.1 Global Oral Rabies Vaccine Sales Market Share by Manufacturers (2020-2025)
    2.2 Global Oral Rabies Vaccine Revenue Market Share by Manufacturers (2020-2025)
    2.3 Global Oral Rabies Vaccine Average Price by Manufacturers (2020-2025)
    2.4 Global Key Players of Oral Rabies Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
    2.5 Global Key Manufacturers of Oral Rabies Vaccine, Manufacturing Sites & Headquarters
    2.6 Global Key Manufacturers of Oral Rabies Vaccine, Product Type & Application
    2.7 Global Key Manufacturers of Oral Rabies Vaccine, Date of Enter into This Industry
    2.8 Global Oral Rabies Vaccine Market Competitive Situation and Trends
        2.8.1 Global Oral Rabies Vaccine Market Concentration Rate
        2.8.2 The Global 5 and 10 Largest Oral Rabies Vaccine Players Market Share by Revenue
        2.8.3 Global Oral Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Oral Rabies Vaccine Market Scenario by Region
    3.1 Global Oral Rabies Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
    3.2 Global Oral Rabies Vaccine Sales by Region: 2020-2031
        3.2.1 Global Oral Rabies Vaccine Sales by Region: 2020-2025
        3.2.2 Global Oral Rabies Vaccine Sales by Region: 2026-2031
    3.3 Global Oral Rabies Vaccine Revenue by Region: 2020-2031
        3.3.1 Global Oral Rabies Vaccine Revenue by Region: 2020-2025
        3.3.2 Global Oral Rabies Vaccine Revenue by Region: 2026-2031
    3.4 North America Oral Rabies Vaccine Market Facts & Figures by Country
        3.4.1 North America Oral Rabies Vaccine Market Size by Country: 2020 VS 2024 VS 2031
        3.4.2 North America Oral Rabies Vaccine Sales by Country (2020-2031)
        3.4.3 North America Oral Rabies Vaccine Revenue by Country (2020-2031)
        3.4.4 United States
        3.4.5 Canada
    3.5 Europe Oral Rabies Vaccine Market Facts & Figures by Country
        3.5.1 Europe Oral Rabies Vaccine Market Size by Country: 2020 VS 2024 VS 2031
        3.5.2 Europe Oral Rabies Vaccine Sales by Country (2020-2031)
        3.5.3 Europe Oral Rabies Vaccine Revenue by Country (2020-2031)
        3.5.4 Germany
        3.5.5 France
        3.5.6 U.K.
        3.5.7 Italy
        3.5.8 Russia
    3.6 Asia Pacific Oral Rabies Vaccine Market Facts & Figures by Region
        3.6.1 Asia Pacific Oral Rabies Vaccine Market Size by Region: 2020 VS 2024 VS 2031
        3.6.2 Asia Pacific Oral Rabies Vaccine Sales by Region (2020-2031)
        3.6.3 Asia Pacific Oral Rabies Vaccine Revenue by Region (2020-2031)
        3.6.4 China
        3.6.5 Japan
        3.6.6 South Korea
        3.6.7 India
        3.6.8 Australia
        3.6.9 China Taiwan
        3.6.10 Southeast Asia
    3.7 Latin America Oral Rabies Vaccine Market Facts & Figures by Country
        3.7.1 Latin America Oral Rabies Vaccine Market Size by Country: 2020 VS 2024 VS 2031
        3.7.2 Latin America Oral Rabies Vaccine Sales by Country (2020-2031)
        3.7.3 Latin America Oral Rabies Vaccine Revenue by Country (2020-2031)
        3.7.4 Mexico
        3.7.5 Brazil
        3.7.6 Argentina
    3.8 Middle East and Africa Oral Rabies Vaccine Market Facts & Figures by Country
        3.8.1 Middle East and Africa Oral Rabies Vaccine Market Size by Country: 2020 VS 2024 VS 2031
        3.8.2 Middle East and Africa Oral Rabies Vaccine Sales by Country (2020-2031)
        3.8.3 Middle East and Africa Oral Rabies Vaccine Revenue by Country (2020-2031)
        3.8.4 Turkey
        3.8.5 Saudi Arabia
        3.8.6 UAE

4 Segment by Type
    4.1 Global Oral Rabies Vaccine Sales by Type (2020-2031)
        4.1.1 Global Oral Rabies Vaccine Sales by Type (2020-2025)
        4.1.2 Global Oral Rabies Vaccine Sales by Type (2026-2031)
        4.1.3 Global Oral Rabies Vaccine Sales Market Share by Type (2020-2031)
    4.2 Global Oral Rabies Vaccine Revenue by Type (2020-2031)
        4.2.1 Global Oral Rabies Vaccine Revenue by Type (2020-2025)
        4.2.2 Global Oral Rabies Vaccine Revenue by Type (2026-2031)
        4.2.3 Global Oral Rabies Vaccine Revenue Market Share by Type (2020-2031)
    4.3 Global Oral Rabies Vaccine Price by Type (2020-2031)

5 Segment by Application
    5.1 Global Oral Rabies Vaccine Sales by Application (2020-2031)
        5.1.1 Global Oral Rabies Vaccine Sales by Application (2020-2025)
        5.1.2 Global Oral Rabies Vaccine Sales by Application (2026-2031)
        5.1.3 Global Oral Rabies Vaccine Sales Market Share by Application (2020-2031)
    5.2 Global Oral Rabies Vaccine Revenue by Application (2020-2031)
        5.2.1 Global Oral Rabies Vaccine Revenue by Application (2020-2025)
        5.2.2 Global Oral Rabies Vaccine Revenue by Application (2026-2031)
        5.2.3 Global Oral Rabies Vaccine Revenue Market Share by Application (2020-2031)
    5.3 Global Oral Rabies Vaccine Price by Application (2020-2031)

6 Key Companies Profiled
    6.1 Boehringer Ingelheim(Merial)
        6.1.1 Boehringer Ingelheim(Merial) Company Information
        6.1.2 Boehringer Ingelheim(Merial) Description and Business Overview
        6.1.3 Boehringer Ingelheim(Merial) Oral Rabies Vaccine Sales, Revenue and Gross Margin (2020-2025)
        6.1.4 Boehringer Ingelheim(Merial) Oral Rabies Vaccine Product Portfolio
        6.1.5 Boehringer Ingelheim(Merial) Recent Developments/Updates
    6.2 Ceva Santé Animale(Artemis Technologies)
        6.2.1 Ceva Santé Animale(Artemis Technologies) Company Information
        6.2.2 Ceva Santé Animale(Artemis Technologies) Description and Business Overview
        6.2.3 Ceva Santé Animale(Artemis Technologies) Oral Rabies Vaccine Sales, Revenue and Gross Margin (2020-2025)
        6.2.4 Ceva Santé Animale(Artemis Technologies) Oral Rabies Vaccine Product Portfolio
        6.2.5 Ceva Santé Animale(Artemis Technologies) Recent Developments/Updates
    6.3 Virbac
        6.3.1 Virbac Company Information
        6.3.2 Virbac Description and Business Overview
        6.3.3 Virbac Oral Rabies Vaccine Sales, Revenue and Gross Margin (2020-2025)
        6.3.4 Virbac Oral Rabies Vaccine Product Portfolio
        6.3.5 Virbac Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis
    7.1 Oral Rabies Vaccine Industry Chain Analysis
    7.2 Oral Rabies Vaccine Raw Material Supply Analysis
        7.2.1 Key Raw Materials
        7.2.2 Raw Materials Key Suppliers
    7.3 Oral Rabies Vaccine Production Mode & Process Analysis
    7.4 Oral Rabies Vaccine Sales and Marketing
        7.4.1 Oral Rabies Vaccine Sales Channels
        7.4.2 Oral Rabies Vaccine Distributors
    7.5 Oral Rabies Vaccine Customer Analysis

8 Oral Rabies Vaccine Market Dynamics
    8.1 Oral Rabies Vaccine Industry Trends
    8.2 Oral Rabies Vaccine Market Drivers
    8.3 Oral Rabies Vaccine Market Challenges
    8.4 Oral Rabies Vaccine Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source
    10.1 Methodology/Research Approach
        10.1.1 Research Programs/Design
        10.1.2 Market Size Estimation
        10.1.3 Market Breakdown and Data Triangulation
    10.2 Data Source
        10.2.1 Secondary Sources
        10.2.2 Primary Sources
    10.3 Author List
    10.4 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Oral Rabies Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Oral Rabies Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Oral Rabies Vaccine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Oral Rabies Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Oral Rabies Vaccine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Oral Rabies Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Oral Rabies Vaccine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Oral Rabies Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Oral Rabies Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Oral Rabies Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Oral Rabies Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Oral Rabies Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Oral Rabies Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Rabies Vaccine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Oral Rabies Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Oral Rabies Vaccine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Oral Rabies Vaccine Sales Market Share by Region (2020-2025)
 Table 19. Global Oral Rabies Vaccine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Oral Rabies Vaccine Sales Market Share by Region (2026-2031)
 Table 21. Global Oral Rabies Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Oral Rabies Vaccine Revenue Market Share by Region (2020-2025)
 Table 23. Global Oral Rabies Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Oral Rabies Vaccine Revenue Market Share by Region (2026-2031)
 Table 25. North America Oral Rabies Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Oral Rabies Vaccine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Oral Rabies Vaccine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Oral Rabies Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Oral Rabies Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Oral Rabies Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Oral Rabies Vaccine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Oral Rabies Vaccine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Oral Rabies Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Oral Rabies Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Oral Rabies Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Oral Rabies Vaccine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Oral Rabies Vaccine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Oral Rabies Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Oral Rabies Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Oral Rabies Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Oral Rabies Vaccine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Oral Rabies Vaccine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Oral Rabies Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Oral Rabies Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Oral Rabies Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Oral Rabies Vaccine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Oral Rabies Vaccine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Oral Rabies Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Oral Rabies Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Oral Rabies Vaccine Sales (K Units) by Type (2020-2025)
 Table 51. Global Oral Rabies Vaccine Sales (K Units) by Type (2026-2031)
 Table 52. Global Oral Rabies Vaccine Sales Market Share by Type (2020-2025)
 Table 53. Global Oral Rabies Vaccine Sales Market Share by Type (2026-2031)
 Table 54. Global Oral Rabies Vaccine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Oral Rabies Vaccine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Oral Rabies Vaccine Revenue Market Share by Type (2020-2025)
 Table 57. Global Oral Rabies Vaccine Revenue Market Share by Type (2026-2031)
 Table 58. Global Oral Rabies Vaccine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Oral Rabies Vaccine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Oral Rabies Vaccine Sales (K Units) by Application (2020-2025)
 Table 61. Global Oral Rabies Vaccine Sales (K Units) by Application (2026-2031)
 Table 62. Global Oral Rabies Vaccine Sales Market Share by Application (2020-2025)
 Table 63. Global Oral Rabies Vaccine Sales Market Share by Application (2026-2031)
 Table 64. Global Oral Rabies Vaccine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Oral Rabies Vaccine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Oral Rabies Vaccine Revenue Market Share by Application (2020-2025)
 Table 67. Global Oral Rabies Vaccine Revenue Market Share by Application (2026-2031)
 Table 68. Global Oral Rabies Vaccine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Oral Rabies Vaccine Price (US$/Unit) by Application (2026-2031)
 Table 70. Boehringer Ingelheim(Merial) Company Information
 Table 71. Boehringer Ingelheim(Merial) Description and Business Overview
 Table 72. Boehringer Ingelheim(Merial) Oral Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Boehringer Ingelheim(Merial) Oral Rabies Vaccine Product
 Table 74. Boehringer Ingelheim(Merial) Recent Developments/Updates
 Table 75. Ceva Santé Animale(Artemis Technologies) Company Information
 Table 76. Ceva Santé Animale(Artemis Technologies) Description and Business Overview
 Table 77. Ceva Santé Animale(Artemis Technologies) Oral Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Ceva Santé Animale(Artemis Technologies) Oral Rabies Vaccine Product
 Table 79. Ceva Santé Animale(Artemis Technologies) Recent Developments/Updates
 Table 80. Virbac Company Information
 Table 81. Virbac Description and Business Overview
 Table 82. Virbac Oral Rabies Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Virbac Oral Rabies Vaccine Product
 Table 84. Virbac Recent Developments/Updates
 Table 85. Key Raw Materials Lists
 Table 86. Raw Materials Key Suppliers Lists
 Table 87. Oral Rabies Vaccine Distributors List
 Table 88. Oral Rabies Vaccine Customers List
 Table 89. Oral Rabies Vaccine Market Trends
 Table 90. Oral Rabies Vaccine Market Drivers
 Table 91. Oral Rabies Vaccine Market Challenges
 Table 92. Oral Rabies Vaccine Market Restraints
 Table 93. Research Programs/Design for This Report
 Table 94. Key Data Information from Secondary Sources
 Table 95. Key Data Information from Primary Sources
 Table 96. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Oral Rabies Vaccine
 Figure 2. Global Oral Rabies Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Oral Rabies Vaccine Market Share by Type: 2024 & 2031
 Figure 4. Modified Live Virus Product Picture
 Figure 5. Recombinant Vaccinia Product Picture
 Figure 6. Recombinant Adenovirus Vaccine Product Picture
 Figure 7. Global Oral Rabies Vaccine Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Oral Rabies Vaccine Market Share by Application: 2024 & 2031
 Figure 9. Government
 Figure 10. Commercial
 Figure 11. Global Oral Rabies Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Oral Rabies Vaccine Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Oral Rabies Vaccine Sales (2020-2031) & (K Units)
 Figure 14. Global Oral Rabies Vaccine Average Price (US$/Unit) & (2020-2031)
 Figure 15. Oral Rabies Vaccine Report Years Considered
 Figure 16. Oral Rabies Vaccine Sales Share by Manufacturers in 2024
 Figure 17. Global Oral Rabies Vaccine Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Oral Rabies Vaccine Players: Market Share by Revenue in Oral Rabies Vaccine in 2024
 Figure 19. Oral Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Oral Rabies Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Oral Rabies Vaccine Sales Market Share by Country (2020-2031)
 Figure 22. North America Oral Rabies Vaccine Revenue Market Share by Country (2020-2031)
 Figure 23. United States Oral Rabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Oral Rabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Oral Rabies Vaccine Sales Market Share by Country (2020-2031)
 Figure 26. Europe Oral Rabies Vaccine Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Oral Rabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Oral Rabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Oral Rabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Oral Rabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Oral Rabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Oral Rabies Vaccine Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Oral Rabies Vaccine Revenue Market Share by Region (2020-2031)
 Figure 34. China Oral Rabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Oral Rabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Oral Rabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Oral Rabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Oral Rabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Oral Rabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Oral Rabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Oral Rabies Vaccine Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Oral Rabies Vaccine Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Oral Rabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Oral Rabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Oral Rabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Oral Rabies Vaccine Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Oral Rabies Vaccine Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Oral Rabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Oral Rabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Oral Rabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Oral Rabies Vaccine by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Oral Rabies Vaccine by Type (2020-2031)
 Figure 53. Global Oral Rabies Vaccine Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Oral Rabies Vaccine by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Oral Rabies Vaccine by Application (2020-2031)
 Figure 56. Global Oral Rabies Vaccine Price (US$/Unit) by Application (2020-2031)
 Figure 57. Oral Rabies Vaccine Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed

Description

The global market for Oral Rabies Vaccine was valued at US$ 116 million in the year 2024 and is projected to reach a revised size of US$ 415 million by 2031, growing at a CAGR of 20.3% during the forecast period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Oral Rabies Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Rabies Vaccine.

The Oral Rabies Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oral Rabies Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. 
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Oral Rabies Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Related Reports

Global Oral Rabies Vaccine Market Research Report 2023
According to QYResearch’s new survey, global Oral Rabies Vaccine market is projected to reach US$ 29
Published: 2023-07-28
Pages: 71
USD 2900.00
(Single User License)
Global Oral Rabies Vaccine Market Report, History and Forecast 2018-2029, Breakdown Data by Manufacturers, Key Regions, Types and Application
Oral Rabies Vaccine report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impa
Published: 2023-07-29
Pages: 73
USD 3350.00
(Single User License)
Global Oral Rabies Vaccine Market Insights, Forecast to 2029
Global Oral Rabies Vaccine market is expected to reach to US$ 98 million in 2023, with a positive gr
Published: 2023-08-28
Pages: 77
USD 4900.00
(Single User License)
Oral Rabies Vaccine - Global Market Insights and Sales Trends 2024
The global Oral Rabies Vaccine market size is expected to reach US$ 297 million by 2029, growing at
Published: 2023-12-29
Pages: 74
USD 3350.00
(Single User License)
Oral Rabies Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Oral Rabies Vaccine was estimated to be worth US$ 80 million in 2023 and is fo
Published: 2024-02-19
Pages: 82
USD 3950.00
(Single User License)
Oral Rabies Vaccine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Oral Rabies Vaccine was estimated to be worth US$ 116 million in 2024 and is f
Published: 2025-03-02
Pages: 84
USD 3950.00
(Single User License)